Source:http://linkedlifedata.com/resource/pubmed/id/21571042
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2011-6-6
|
pubmed:abstractText |
Sepsis induces multiple organ dysfunction syndrome including septic encephalopathy (SE), which results in cognitive impairment. However, an effective treatment for SE remains unknown. We determined the role of interleukin-1? (IL-1?) in long-term potentiation (LTP) deficiency after SE. At first, endotoxin level in the blood was increased at 24 h after cecum ligation and puncture (CLP) (i.e. SE model). Second, the expression of IL-1? and its receptor in the hippocampus was determined by immunohistochemistry and immunoblotting. The number of Iba1-positive cells and their expression of IL-1? were enhanced by CLP with disruption of the blood brain barrier. Also, Iba1, IL-1?, and occludin protein expressions were consistent with immunohistochemical results. Third, we used an electrophysiological technique and observed the LTP deficiency, a hallmark of learning and memory, in the slices of hippocampus after CLP. Since type 1 interleukin-1 receptors (IL-1R1s) on neuronal cells were increased in the hippocampus, we utilized IL-1R1 antagonist. Pre-incubation with IL-1R1 antagonist for 30 min before recording of field excitatory post-synaptic potentials (fEPSPs) in the hippocampus canceled LTP deficiency after CLP. These results suggest the novel importance of IL-1? in synaptic plasticity deficiency associated with sepsis-induced brain inflammation. In a mouse model of SE, IL-1R1 inhibition is important in protecting synaptic function of the hippocampus after induction of SE.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1873-7544
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright © 2011 IBRO. Published by Elsevier Ltd. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
28
|
pubmed:volume |
187
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
63-9
|
pubmed:meshHeading |
pubmed-meshheading:21571042-Animals,
pubmed-meshheading:21571042-Disease Models, Animal,
pubmed-meshheading:21571042-Encephalitis,
pubmed-meshheading:21571042-Excitatory Postsynaptic Potentials,
pubmed-meshheading:21571042-Hippocampus,
pubmed-meshheading:21571042-Immunoblotting,
pubmed-meshheading:21571042-Immunohistochemistry,
pubmed-meshheading:21571042-Interleukin-1beta,
pubmed-meshheading:21571042-Long-Term Potentiation,
pubmed-meshheading:21571042-Male,
pubmed-meshheading:21571042-Mice,
pubmed-meshheading:21571042-Mice, Inbred C57BL,
pubmed-meshheading:21571042-Receptors, Interleukin-1,
pubmed-meshheading:21571042-Systemic Inflammatory Response Syndrome
|
pubmed:year |
2011
|
pubmed:articleTitle |
Interleukin-1? causes long-term potentiation deficiency in a mouse model of septic encephalopathy.
|
pubmed:affiliation |
Department of Trauma and Acute Critical Care Center, Osaka University Hospital, Osaka, Japan. yimamura-ns@umin.net
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|